Pharmafile Logo
Pharmafocus logo
Advanced Search

EU approves Onureg for patients with acute myeloid leukemia

June 21, 2021
Sales and Marketing

The European Commission has approved Onureg as frontline oral maintenance therapy for patients with a broad range of acute myeloid …

News

Alzheimer’s drug approval: Advocacy group calls for FDA resignations

June 21, 2021
Sales and Marketing

Public Citizen, the US consumer advocacy group, has called for the resignation of three top FDA officials following the approval …

News
novartis_window

Novartis’s Zolgensma for SMA shows ‘extraordinary’ results

June 21, 2021
Sales and Marketing

New late-breaker data from the Phase III trial for Zolgensma, the world’s most expensive drug, has shown positive results. Zolgensma …

News
sanofi_hq__boetie_hall_web

EU approves Aubagio for children living with MS

June 21, 2021
Sales and Marketing

The EU has approved Aubagio (teriflunomide) for the treatment of paediatric patients 10 to 17 years of age with relapsing-remitting …

News

Breakthrough announced in circulating tumour cell research

June 18, 2021
Medical Communications Cancer, Circulating tumour cells, Precision Medicine, oncology

Liquid biopsy company, Angle, has announced results from their study in non-small cell lung cancer (NSCLC) which demonstrates the benefit …

News

UK AI firm wins share of £140 million funding for lung cancer detection tech

June 18, 2021
Medical Communications AI, CT, NHS, funding, lunch cancer, screening, technology

Artificial intelligence firm Behold.ai has won a share of £140 million in government funding for its red dot lung cancer …

News
astrazeneca_plaque

Australia pauses AstraZeneca vaccine for people under 60

June 18, 2021
Medical Communications AstraZeneca, Australia, COVID-19, Vaccine

Australia will now only recommend that people over 60 receive the AstraZeneca vaccine due to the rare occurrence of post-jab …

News

New class of cancer-killing drugs identified

June 18, 2021
Medical Communications Cancer, oncology

Scientists have announced the identification of a new class of cancer drugs, known as POLQ inhibitors, that specifically kill cancer …

News

NICE recommends two new treatments for inflammatory arthritis

June 18, 2021
Medical Communications Eli Lilly, NICE, Novartis

NICE has recommended two new treatments for axial spondyloarthritis, an underdiagnosed and debilitating type of inflammatory arthritis. Ixekizumab (also known …

News

Prostate cancer detection system wins government funding

June 17, 2021

A prostate cancer detection software system, to help pathologists quickly identify suspicious areas of tissue, has won government funding. The …

News

Exscientia buys Austrian cancer cell screening company for €50 million

June 17, 2021
AI, EU, deal, marketing, sales

UK-based AI pioneers Exscientia has announced the purchase of rival AI firm Allcyte for €50 million. The multimillion deal, paid …

News

NHS to pilot artificial pancreas for type 1 diabetes

June 17, 2021
NHS, diabetes, insulin, technology, wearable technology

The NHS has announced that artificial pancreases will be available to patients with type 1 diabetes, with up to 1,000 …

News

Biogen’s Phase II Alzheimer’s study misses primary endpoint

June 17, 2021

Biogen’s Phase II study for gosuranemab, an anti-tau antibody for Alzheimer’s disease, did not meet its primary endpoint, and has …

News
img_4190-e1376666350337-web

Epilepsy drug receives MHRA marketing authorisation

June 17, 2021
MHRA, epilepsy, marketing authorisation

The MHRA has granted marketing authorisation (MA) for Ontozry (cenobamate) for the treatment of focal-onset seizures in adult patients with …

News

UK COVID vaccine update

June 16, 2021
Research and Development COVID-19, UK, care homes, children, government, vaccines

Care home staff vaccinations to be compulsory COVID-19 vaccinations among care home staff are to become mandatory, the Guardian has …

News
covid_cell_1_20

Pharmafile.com’s weekly COVID-19 news round-up

June 16, 2021
Research and Development

The past week has seen quite a mixed bag when it comes to COVID-19 news, an AstraZeneca antibody has failed …

News

Ground-breaking COVID antibody treatment proven to save lives

June 16, 2021
Research and Development COVID-19, UK, antibodies, trial

Results from Regeneron’s Recovery trial, investigating a potent monoclonal antibody combination treatment in hospitalised patients with severe COVID-19, have shown …

News

Signite’s sustainable decorating solution to reduce label waste by 50%

June 16, 2021
Research and Development

ACTEGA has officially launched Signite, a new decorating solution designed to significantly reduce waste in label production. The hope is …

News

Avadel’s narcolepsy Phase III trial shows positive results

June 16, 2021
Research and Development

Avadel’s Phase III trial for FT218 in patients with narcolepsy has shown positive results. The data from the trial demonstrated …

News
az

AstraZeneca antibody fails to prevent COVID in exposed patients

June 15, 2021
Manufacturing and Production AstraZeneca, COVID-19, Primary Endpoint, antibody, trial

AstraZeneca has failed to reach the primary endpoint in their Storm Chaser trial, assessing the safety and efficacy of AZD7442, …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026